Human Epigenome Project
Human Epigenome Project (HEP) is a multinational science project, with the stated aim to "identify, catalog, and interpret genome-wide DNA methylation patterns of all human genes in all major tissues".[1] It is financed by government funds as well as private investment, via a consortium of genetic research organisations.
The call for such a project was widely suggested and supported by cancer research scientists from all over the world.[2][3][4][5]
Consortium
[edit]The HEP consortium is made up of the following organizations:[citation needed]
- The Wellcome Trust Sanger Institute — UK
- Epigenomics AG — Germany/USA
- The Centre National de Génotypage — France
See also
[edit]References
[edit]- ↑ "Description Page". Human Epigenome Project. Archived from the original on 2009-10-10. Retrieved 2009-01-30.
- ↑ Esteller M (2006). "The necessity of a human epigenome project". Carcinogenesis. 27 (6): 1121–1125. doi:10.1093/carcin/bgl033. PMID 16699174.
- ↑ Jones PA, Martienssen R (2005). "A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop". Cancer Res. 65 (24): 11241–11246. doi:10.1158/0008-5472.CAN-05-3865. PMID 16357125.
- ↑ Rauscher FJ 3rd (2005). "It is time for a Human Epigenome Project". Cancer Res. 65 (24): 11229. doi:10.1158/0008-5472.can-65-24-ed1. PMID 16357122.
{{cite journal}}: CS1 maint: numeric names: authors list (link) - ↑ Bradbury J (2003). "Human epigenome project--up and running". PLOS Biol. 1 (3): E82. doi:10.1371/journal.pbio.0000082. PMC 300691. PMID 14691553.
| Fields | |
|---|---|
| Bioinformatics | |
| Structural biology | |
| Research tools | |
| Organizations | |
 | This genetics article is a stub. You can help Wikipedia by adding missing information. |